PECA Labs
pecalabs.com
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$17.3M
8 rounds on record
Latest round
$2.7M
Venture round · Nov 2025 · 11 mo ago
Team
51-200
employees, estimated range
Grants
$1.5M
3 grants · CORDIS
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 6, 2025
Raised a round Venture round $2.7M · SEC Form D
Aug 1, 2025
Won a grant $306k · CORDIS
Dec 12, 2024
Raised a round Venture round $13.9M · SEC Form D
Nov 9, 2022
Took on debt financing $618k · SEC Form D
Jun 30, 2021
Raised a round Venture round $99k · SEC Form D
Jun 15, 2020
Board appointment James Browne, Director · SEC Form D
Jun 5, 2020
Raised a round Venture round $587k · SEC Form D
Apr 15, 2019
Won a grant $998k · CORDIS
Apr 1, 2017
Won a grant $149k · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2025 | $2.7M | — | SEC Form D |
| Grant | Aug 2025 | $306k | — | CORDIS |
| Venture round | Dec 2024 | $13.9M | — | SEC Form D |
| Debt Financing | Nov 2022 | $618k | — | SEC Form D |
| Venture round | Jun 2021 | $99k | — | SEC Form D |
| Venture round | Jun 2020 | $587k | — | SEC Form D |
| Grant | Apr 2019 | $998k | — | CORDIS |
| Grant | Apr 2017 | $149k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Peca Labs, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
C. Douglas BernsteinExecutive Officer, DirectorSEC Form D
David SmithExecutive OfficerSEC Form D
Douglas BernsteinExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Inner Logic
Similar startupsby what they do, their industry and backers
Frontier Bio develops living vascular grafts and in-vitro tissue platforms, building the foundation for organ-scale engineered tissues.
The development infrastructure for the next generation of procedural devices.
Company Technology Application Contact Company ArtiFex Medical GmbH, founded in 2020 in Vienna as a spin-off from University Hospital…
Transforming the treatment of cardiovascular disease and heart failure.
We are a national network of clinicians dedicated to advancing the field of cardiovascular care and delivering best-in-class patient…
Developing the next generation of left-heart access technologies.
Overview
The future of cardiovascular implantable devices. The next generation of vascular grafts with first-in-class features for children and adults.
People
C. Douglas Bernstein
Executive Officer, Director
David Smith
Executive Officer
Douglas Bernstein
Executive Officer, Director
Brandon Haynes
Director
Dr. Joseph Bavaria
Director
Barbara Carryer
Director
Jon Kuhn
Director
Dr. Jeffrey Carpenter
Director
Michael Moriarty
Director
Samuel Navarro
Director
Jeff ODonnell
Director
James Browne
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Pittsburgh
United States
HQ
50-200 est. staff
Financials
Total raised
$19.3M
Latest round
Venture - Series Unknown
Funding rounds
8
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $2.7M | Details |
| Grant | 2025 | $306k | Details |
| Venture - Series Unknown | 2024 | $13.9M | Details |
| Debt Financing | 2022 | $618k | Details |
| Venture - Series Unknown | 2021 | $99k | Details |
| Venture - Series Unknown | 2020 | $587k | Details |
| Grant | 2019 | $998k | Details |
| Grant | 2017 | $149k | Details |